Published in Front Genet on March 04, 2015
Implication of sphingosin-1-phosphate in cardiovascular regulation. Front Biosci (Landmark Ed) (2016) 0.77
Gastric bypass surgery reveals independency of obesity and diabetes melitus type 2. BMC Endocr Disord (2016) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems. Nat Rev Genet (2008) 9.26
Weak pairwise correlations imply strongly correlated network states in a neural population. Nature (2006) 9.18
A perspective on epistasis: limits of models displaying no main effect. Am J Hum Genet (2002) 5.63
Identifying SNPs predictive of phenotype using random forests. Genet Epidemiol (2005) 5.43
Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am J Hum Genet (2010) 5.39
A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med (2008) 4.61
The structure of multi-neuron firing patterns in primate retina. J Neurosci (2006) 4.49
A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet (2009) 4.28
Genetic architecture of complex traits: large phenotypic effects and pervasive epistasis. Proc Natl Acad Sci U S A (2008) 3.56
Modeling quantitative trait Loci and interpretation of models. Genetics (2005) 3.15
A maximum entropy model applied to spatial and temporal correlations from cortical networks in vitro. J Neurosci (2008) 2.65
Epistasis dominates the genetic architecture of Drosophila quantitative traits. Proc Natl Acad Sci U S A (2012) 2.59
A unified model for functional and statistical epistasis and its application in quantitative trait Loci analysis. Genetics (2007) 2.47
Molecular mechanisms of epistasis within and between genes. Trends Genet (2011) 1.98
The metabolism and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci (2007) 1.89
Prevalence of gallstones in a Danish population. Am J Epidemiol (1987) 1.79
Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science (2014) 1.77
An entropy-based approach for testing genetic epistasis underlying complex diseases. J Theor Biol (2007) 1.56
Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol (2011) 1.51
Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res (2003) 1.46
Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program. Eur J Hum Genet (2008) 1.45
On epistasis: why it is unimportant in polygenic directional selection. Philos Trans R Soc Lond B Biol Sci (2010) 1.36
Multiple biomarkers and the risk of incident hypertension. Hypertension (2007) 1.34
The powerful law of the power law and other myths in network biology. Mol Biosyst (2009) 1.29
Sphingolipid signalling in the cardiovascular system: good, bad or both? Eur J Pharmacol (2008) 1.25
Sphingosine-1-phosphate and modulation of vascular tone. Cardiovasc Res (2009) 1.19
Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation (2002) 1.17
Sphingolipid signaling and redox regulation. Free Radic Biol Med (2006) 1.12
Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology. Cardiovasc Res (2009) 1.12
Genetic basis of polygenic hypertension. Hum Mol Genet (2007) 1.09
Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proc Natl Acad Sci U S A (1999) 1.04
A general model for multilocus epistatic interactions in case-control studies. PLoS One (2010) 0.99
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
Hereditary determinants of human hypertension: strategies in the setting of genetic complexity. Hypertension (2008) 0.95
Scale-freeness and biological networks. J Biochem (2005) 0.95
Genetics and hypertension. J Clin Hypertens (Greenwich) (2007) 0.93
Recent progress on the analysis of power-law features in complex cellular networks. Cell Biochem Biophys (2007) 0.91
Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.91
Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension. BMC Genet (2011) 0.88
Secondary hypertension: obesity and the metabolic syndrome. J Clin Hypertens (Greenwich) (2008) 0.87
Impaired ceramide signalling in spontaneously hypertensive rat vascular smooth muscle: a possible mechanism for augmented cell proliferation. J Hypertens (2001) 0.87
Analysis of heterogeneity and epistasis in physiological mixed populations by combined structural equation modelling and latent class analysis. BMC Genet (2008) 0.85
Activation of sphingosine kinase by muscarinic receptors enhances NO-mediated and attenuates EDHF-mediated vasorelaxation. Basic Res Cardiol (2008) 0.84
Phospholipase D1 is threonine-phosphorylated in human-airway epithelial cells stimulated by sphingosine-1-phosphate by a mechanism involving Src tyrosine kinase and protein kinase Cdelta. Biochem J (2002) 0.81
Current status of genome-wide scanning for hypertension. Curr Opin Cardiol (2007) 0.81
Next generation genetics. Front Genet (2014) 0.79
Q192R Paraoxonase (PON)1 Polymorphism, Insulin Sensitivity, and Endothelial Function in Essential Hypertensive Men. Clin Med Insights Cardiol (2014) 0.76